Januvia Merck & Co., Inc. - Treatment for Type 2 Diabetes

Januvia is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

Posted: October 2006

Related Articles:

Januvia (sitagliptin phosphate) FDA Approval History

Comments

(web2)